CA2222646C - Compositions and methods for stabilizing polymers - Google Patents

Compositions and methods for stabilizing polymers Download PDF

Info

Publication number
CA2222646C
CA2222646C CA002222646A CA2222646A CA2222646C CA 2222646 C CA2222646 C CA 2222646C CA 002222646 A CA002222646 A CA 002222646A CA 2222646 A CA2222646 A CA 2222646A CA 2222646 C CA2222646 C CA 2222646C
Authority
CA
Canada
Prior art keywords
composition
weight percent
chelating agent
poly
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002222646A
Other languages
English (en)
French (fr)
Other versions
CA2222646A1 (en
Inventor
Fu-Pao Tsao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA2222646A1 publication Critical patent/CA2222646A1/en
Application granted granted Critical
Publication of CA2222646C publication Critical patent/CA2222646C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/49—Phosphorus-containing compounds
    • C08K5/51—Phosphorus bound to oxygen
    • C08K5/53—Phosphorus bound to oxygen bound to oxygen and to carbon only
    • C08K5/5317—Phosphonic compounds, e.g. R—P(:O)(OR')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
CA002222646A 1995-06-22 1996-06-12 Compositions and methods for stabilizing polymers Expired - Fee Related CA2222646C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/493,761 US5683993A (en) 1995-06-22 1995-06-22 Compositions and methods for stabilizing polymers
US08/493,761 1995-06-22
PCT/EP1996/002539 WO1997000669A1 (en) 1995-06-22 1996-06-12 Compositions and methods for stabilizing polymers

Publications (2)

Publication Number Publication Date
CA2222646A1 CA2222646A1 (en) 1997-01-09
CA2222646C true CA2222646C (en) 2009-12-08

Family

ID=23961593

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222646A Expired - Fee Related CA2222646C (en) 1995-06-22 1996-06-12 Compositions and methods for stabilizing polymers

Country Status (13)

Country Link
US (2) US5683993A (da)
EP (1) EP0833609B1 (da)
JP (3) JP4260881B2 (da)
AT (1) ATE208189T1 (da)
AU (1) AU715686B2 (da)
CA (1) CA2222646C (da)
CY (1) CY2323B1 (da)
DE (1) DE69616791T2 (da)
DK (1) DK0833609T3 (da)
ES (1) ES2167581T3 (da)
PT (1) PT833609E (da)
TW (1) TW358109B (da)
WO (1) WO1997000669A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051281A1 (fr) * 1997-05-14 1998-11-19 Senju Pharmaceutical Co., Ltd. Preparations a base de suspensions aqueuses possedant d'excellentes proprietes de redispersion
ES2174388T3 (es) * 1997-06-27 2002-11-01 Akzo Nobel Nv Solucion liquida de medicamento para administracion oral.
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US6627660B1 (en) * 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
MXPA03004313A (es) 2000-11-17 2007-02-27 Hematech Llc Expresion de inmunoglobulinas xenogenas (humanas) en ungulados transgenicos, clonados.
AU2002360939A1 (en) * 2001-11-21 2003-06-10 Novartis Ag Composition for stabilizing hyaluronic acid
US20040115160A1 (en) * 2002-12-13 2004-06-17 Salamone Joseph C. Quaternary ammonium esters for disinfection and preservation
US20050084468A1 (en) * 2003-10-17 2005-04-21 Colgate-Palmolive Company Antimicrobial cleaning composition
KR20140083056A (ko) * 2006-03-17 2014-07-03 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
JP5160757B2 (ja) * 2006-09-01 2013-03-13 ホーユー株式会社 毛髪脱染剤組成物
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
US20100021561A1 (en) * 2006-09-21 2010-01-28 Chowhan Masood A Self-preserved aqueous pharmaceutical compositions
WO2008042619A2 (en) * 2006-09-28 2008-04-10 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
EP2090314A4 (en) * 2006-10-26 2010-01-13 Senju Pharma Co AQUATIC OPHTHALMIC LIQUID PREPARATION
AU2008233256B2 (en) 2007-03-28 2013-06-27 The Curators Of The University Of Missouri Transgenic animal models of disease
US8759321B2 (en) 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US8119112B2 (en) 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
CA2717679C (en) * 2008-03-17 2013-07-23 Alcon Research, Ltd. Aqueous pharmaceutical compositions containing borate-polyol complexes
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
KR20140034229A (ko) 2011-05-16 2014-03-19 더 큐레이터스 오브 더 유니버시티 오브 미주리 돼지 생식기 호흡기 증후군 바이러스 내성 동물
DK2773952T3 (da) 2011-11-03 2019-04-23 Univ Iowa Res Found Transgene svinemodeller af cystisk fibrose
US20130177599A1 (en) * 2012-01-06 2013-07-11 Insite Vision Incorporated Methods and kits for extending contact lens use
KR101400791B1 (ko) 2012-10-04 2014-05-29 주식회사대성미생물연구소 동물용 복합 기능성 항생제 조성물
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
US10149843B1 (en) 2017-02-07 2018-12-11 Gneus Lifescineces Inc. Pharmaceutical compositions and methods of using the same
US10231961B1 (en) 2017-02-07 2019-03-19 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
US10413505B1 (en) 2017-02-07 2019-09-17 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
CN109387622A (zh) * 2018-03-02 2019-02-26 国家纳米科学中心 一种高分子材料表面修饰方法及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322883A1 (de) * 1973-05-07 1974-11-28 Roehm Gmbh Wasserloesliche polymerisate
DE2743764C2 (de) * 1977-09-29 1982-07-22 Hoechst Ag, 6000 Frankfurt Wäßrige Kunststoffdispersion auf Basis von Vinylpolymeren
DE2810348A1 (de) * 1978-03-10 1979-09-20 Hoechst Ag Waessrige kunststoffdispersion auf basis von vinylpolymeren
US4303568A (en) * 1979-12-10 1981-12-01 Betz Laboratories, Inc. Corrosion inhibition treatments and method
US4474916A (en) * 1982-07-27 1984-10-02 Basf Aktiengesellschaft Concentrated aqueous solutions of mixtures of organic complexing agents and dispersing agents based on polymeric aliphatic carboxylic acids
DE3486448T2 (de) * 1983-11-14 1997-10-09 Columbia Lab Inc Bioadhäsive Mittel
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
US4540738A (en) * 1984-12-07 1985-09-10 The Kendall Company Acrylic adhesive composition comprising an alpha amino phosphonic acid or salt having improved stability
US4889689A (en) * 1986-10-14 1989-12-26 Ciba-Geigy Corporation Method of disinfecting a soft contact lens with a diethylene triamine penta(methylenephosphonic acid) stabilized hydrogen peroxide solution
US4900469A (en) * 1986-10-21 1990-02-13 The Clorox Company Thickened peracid precursor compositions
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
ES2091204T3 (es) * 1988-08-04 1996-11-01 Ciba Geigy Ag Metodo y composiciones para conservar soluciones oftalmicas.
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5034556A (en) * 1989-04-03 1991-07-23 Ppg Industries, Inc. Reaction products of alpha-aminomethylene phosphonic acids and epoxy compounds and their use in coating compositions
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
DE69107056D1 (de) * 1990-11-14 1995-03-09 Oreal Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
US5422073A (en) * 1990-12-27 1995-06-06 Allergan, Inc. Method and composition for disinfecting contact lenses
JP3107873B2 (ja) * 1991-09-26 2000-11-13 ユニ・チャーム株式会社 高吸水性ポリマーの経時着色防止方法および経時着色防止剤
NO303146B1 (no) * 1991-11-26 1998-06-02 Eniricerche Spa Vandig geldannende blanding og anvendelse derav
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
SE500660C2 (sv) * 1992-12-03 1994-08-01 Mo Och Domsjoe Ab Förfarande för framställning av grönlut vid kemikalieåtervinning i sulfat- och sulfitmassafabriker
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE59407521D1 (de) * 1993-08-10 1999-02-04 Ciba Geigy Ag Mercerisiernetzmittel
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds

Also Published As

Publication number Publication date
CA2222646A1 (en) 1997-01-09
AU6355196A (en) 1997-01-22
JP2008248246A (ja) 2008-10-16
PT833609E (pt) 2002-04-29
US5683993A (en) 1997-11-04
EP0833609B1 (en) 2001-11-07
EP0833609A1 (en) 1998-04-08
JPH11510480A (ja) 1999-09-14
WO1997000669A1 (en) 1997-01-09
CY2323B1 (en) 2003-11-14
DE69616791T2 (de) 2002-05-29
ES2167581T3 (es) 2002-05-16
JP4260881B2 (ja) 2009-04-30
DE69616791D1 (de) 2001-12-13
ATE208189T1 (de) 2001-11-15
JP2012153710A (ja) 2012-08-16
AU715686B2 (en) 2000-02-10
DK0833609T3 (da) 2002-02-18
US5858996A (en) 1999-01-12
TW358109B (en) 1999-05-11

Similar Documents

Publication Publication Date Title
CA2222646C (en) Compositions and methods for stabilizing polymers
EP0844868B1 (en) Compositions including O-carboxymethyl chitosan and use in ophthalmics
CA2326137C (en) Method for stabilizing pharmaceutical compositions by special use of an antioxidant
CA2087420C (en) Ophthalmic pharmaceutical composition containing n-acetyl-cisteine and polyvinylalcohol
DE69117509T2 (de) Umkehrbar gelierte zusammensetzungen und verfahren zur verwendung
SK127099A3 (en) Controlled release of pharmaceuticals in the anterior chamber of the eye
US20060100173A1 (en) Ophthalmic solution
EP1480677B1 (en) Composition for stabilizing hyaluronic acid
WO2002072080A2 (de) Lagerstabile fertiginfusionslösungen des paracetamols
WO1993002663A1 (en) Ophthalmic compositions based on polyhydric alcohols
JPH02164829A (ja) ヒアルロン酸点眼液
EP0424042A1 (en) Non-solid ophthalmic composition and process for preparing the said composition
EP0732914B1 (en) Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds
EP0342297A1 (en) Aqueous solution with low surface tension forming a wettable layer over a hydrophobic surface
CZ326499A3 (cs) Kompozice použitelná v oční chirurgii

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140612